Business Description
Eiko Lifesciences Ltd
ISIN : INE666Q01016
Total Employee Number:
7Compare
Compare
Traded in other countries / regions
540204.India IPO Date
2016-12-13Description
Eiko Lifesciences Ltd is a manufacturer, supplier, and exporter of specialty chemicals, fine chemicals, and pharma intermediates.. The company's segment includes Agrochemicals, Oleo Chemicals, Pharmaceuticals, Food Additives, clinical research, development, and Logistics. Geographically, the company generates the majority of its revenue from the Domestic market.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.88 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | 0.56 | |||||
Interest Coverage | 19.47 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.47 | |||||
Beneish M-Score | -1.79 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 25.9 | |||||
3-Year EBITDA Growth Rate | 48.1 | |||||
3-Year EPS without NRI Growth Rate | 60.9 | |||||
3-Year FCF Growth Rate | -26.5 | |||||
3-Year Book Growth Rate | 15.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 41.01 | |||||
9-Day RSI | 43.16 | |||||
14-Day RSI | 44.39 | |||||
3-1 Month Momentum % | 0.53 | |||||
6-1 Month Momentum % | 3.17 | |||||
12-1 Month Momentum % | -4.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.08 | |||||
Quick Ratio | 2.82 | |||||
Cash Ratio | 0.89 | |||||
Days Inventory | 34.9 | |||||
Days Sales Outstanding | 105.12 | |||||
Days Payable | 51.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.7 | |||||
Shareholder Yield % | -12.37 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 21.65 | |||||
Operating Margin % | 12.18 | |||||
Net Margin % | 8.53 | |||||
EBITDA Margin % | 16.06 | |||||
FCF Margin % | 4.33 | |||||
OCF Margin % | 4.33 | |||||
ROE % | 7.32 | |||||
ROA % | 6.12 | |||||
ROIC % | 8.59 | |||||
3-Year ROIIC % | 13.6 | |||||
ROC (Joel Greenblatt) % | 18.55 | |||||
ROCE % | 11.45 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.39 | |||||
PE Ratio without NRI | 15.39 | |||||
Shiller PE Ratio | 67.4 | |||||
Price-to-Owner-Earnings | 119.93 | |||||
PEG Ratio | 0.82 | |||||
PS Ratio | 1.32 | |||||
PB Ratio | 1.03 | |||||
Price-to-Tangible-Book | 1.03 | |||||
Price-to-Free-Cash-Flow | 30.2 | |||||
Price-to-Operating-Cash-Flow | 30.2 | |||||
EV-to-EBIT | 8.46 | |||||
EV-to-EBITDA | 7.45 | |||||
EV-to-Revenue | 1.2 | |||||
EV-to-FCF | 27.61 | |||||
Price-to-GF-Value | 0.61 | |||||
Price-to-Projected-FCF | 3.16 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.09 | |||||
Price-to-Graham-Number | 0.84 | |||||
| Price-to-Net-Current-Asset-Value | 2.64 | |||||
Earnings Yield (Greenblatt) % | 11.82 | |||||
FCF Yield % | 3.22 | |||||
Forward Rate of Return (Yacktman) % | 12.62 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eiko Lifesciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 527.066 | ||
| EPS (TTM) (₹) | 3.18 | ||
| Beta | 0.2533 | ||
| 3-Year Sharpe Ratio | -0.12 | ||
| 3-Year Sortino Ratio | -0.18 | ||
| Volatility % | 23.39 | ||
| 14-Day RSI | 44.39 | ||
| 14-Day ATR (₹) | 1.768918 | ||
| 20-Day SMA (₹) | 49.61 | ||
| 12-1 Month Momentum % | -4.94 | ||
| 52-Week Range (₹) | 45.9 - 64.44 | ||
| Shares Outstanding (Mil) | 14.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eiko Lifesciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eiko Lifesciences Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Eiko Lifesciences Ltd Frequently Asked Questions
What is Eiko Lifesciences Ltd(BOM:540204)'s stock price today?
The current price of BOM:540204 is ₹48.93. The 52 week high of BOM:540204 is ₹64.44 and 52 week low is ₹45.90.
When is next earnings date of Eiko Lifesciences Ltd(BOM:540204)?
The next earnings date of Eiko Lifesciences Ltd(BOM:540204) is .
Does Eiko Lifesciences Ltd(BOM:540204) pay dividends? If so, how much?
Eiko Lifesciences Ltd(BOM:540204) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Eiko Lifesciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers